Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 292

1.

Trends in axillary lymph node dissection for early-stage breast cancer in Europe: Impact of evidence on practice.

Garcia-Etienne CA, Mansel RE, Tomatis M, Heil J, Biganzoli L, Ferrari A, Marotti L, Sgarella A, Ponti A; EUSOMA Working Group.

Breast. 2019 Jun;45:89-96. doi: 10.1016/j.breast.2019.03.002. Epub 2019 Mar 11.

PMID:
30925382
2.

Data managers: A survey of the European Society of Breast Cancer Specialists in certified multi-disciplinary breast centers.

Schnapper G, Marotti L, Casella D, Mano MP, Mansel RE, Ponti A; EUSOMA Breast Centers Network Data Managers.

Breast J. 2018 Sep;24(5):811-815. doi: 10.1111/tbj.13043. Epub 2018 Apr 23.

PMID:
29687531
3.

A Randomized Controlled Multicenter Trial of an Investigational Liquid Nutritional Formula in Women with Cyclic Breast Pain Associated with Fibrocystic Breast Changes.

Mansel RE, Das T, Baggs GE, Noss MJ, Jennings WP, Cohen J, Portman D, Cohen M, Voss AC.

J Womens Health (Larchmt). 2018 Mar;27(3):333-340. doi: 10.1089/jwh.2017.6406. Epub 2017 Dec 13.

4.

Corrigendum to "Loss of tight junction plaque molecules in breast cancer tissues is associated with a poor prognosis in patients with breast cancer" [Eur J Cancer 40 (18) (2004) 2717-2725].

Martin TA, Watkins G, Mansel RE, Jiang WG.

Eur J Cancer. 2018 Jan;88:115-116. doi: 10.1016/j.ejca.2017.11.001. Epub 2017 Nov 23. No abstract available.

PMID:
29174182
5.

Quality indicators in breast cancer care: An update from the EUSOMA working group.

Biganzoli L, Marotti L, Hart CD, Cataliotti L, Cutuli B, Kühn T, Mansel RE, Ponti A, Poortmans P, Regitnig P, van der Hage JA, Wengström Y, Rosselli Del Turco M.

Eur J Cancer. 2017 Nov;86:59-81. doi: 10.1016/j.ejca.2017.08.017. Epub 2017 Sep 28. Review.

PMID:
28963914
6.

Time trends (2006-2015) of quality indicators in EUSOMA-certified breast centres.

van Dam PA, Tomatis M, Marotti L, Heil J, Mansel RE, Rosselli Del Turco M, van Dam PJ, Casella D, Bassani LG, Danei M, Denk A, Egle D, Emons G, Friedrichs K, Harbeck N, Kiechle M, Kimmig R, Koehler U, Kuemmel S, Maass N, Mayr C, Prové A, Rageth C, Regolo L, Lorenz-Salehi F, Sarlos D, Singer C, Sohn C, Staelens G, Tinterri C, Audisio R, Ponti A; eusomaDB Working Group.

Eur J Cancer. 2017 Nov;85:15-22. doi: 10.1016/j.ejca.2017.07.040. Epub 2017 Sep 4.

PMID:
28881247
7.

A multicentre validation of Metasin: a molecular assay for the intraoperative assessment of sentinel lymph nodes from breast cancer patients.

Sai-Giridhar P, Al-Ramadhani S, George D, Gopinath P, Andrews W, Jader S, Brown S, Findlay A, Arkoumani E, Al-Sam S, McKenzie JG, Bradpiece H, Jenkins S, Aylwin A, Holt S, Sharaiha Y, Yiangou C, Agrawal A, McDowell A, Gabriel FG, Jeffrey M, Agrawal N, Cree IA, Mansel RE, Keshtgar M, McDermott N, El Sheikh S, Wellsted D, Collard J, Chaplin H, Landt O, Bustin S, Sundaresan M, Sundaresan V.

Histopathology. 2016 May;68(6):875-87. doi: 10.1111/his.12863. Epub 2016 Jan 4.

PMID:
26383172
8.

Giant pseudoangiomatous stromal hyperplasia presenting in the breast of a prepubertal child.

Abdelrahman T, Young P, Kozyar O, Davies E, Dojcinov S, Mansel RE.

BMJ Case Rep. 2015 May 22;2015. pii: bcr2014206797. doi: 10.1136/bcr-2014-206797.

9.

Radiotherapy or surgery of the axilla after a positive sentinel node in breast cancer (EORTC 10981-22023 AMAROS): a randomised, multicentre, open-label, phase 3 non-inferiority trial.

Donker M, van Tienhoven G, Straver ME, Meijnen P, van de Velde CJ, Mansel RE, Cataliotti L, Westenberg AH, Klinkenbijl JH, Orzalesi L, Bouma WH, van der Mijle HC, Nieuwenhuijzen GA, Veltkamp SC, Slaets L, Duez NJ, de Graaf PW, van Dalen T, Marinelli A, Rijna H, Snoj M, Bundred NJ, Merkus JW, Belkacemi Y, Petignat P, Schinagl DA, Coens C, Messina CG, Bogaerts J, Rutgers EJ.

Lancet Oncol. 2014 Nov;15(12):1303-10. doi: 10.1016/S1470-2045(14)70460-7. Epub 2014 Oct 15.

10.

Anastrozole for prevention of breast cancer in high-risk postmenopausal women (IBIS-II): an international, double-blind, randomised placebo-controlled trial.

Cuzick J, Sestak I, Forbes JF, Dowsett M, Knox J, Cawthorn S, Saunders C, Roche N, Mansel RE, von Minckwitz G, Bonanni B, Palva T, Howell A; IBIS-II investigators.

Lancet. 2014 Mar 22;383(9922):1041-8. doi: 10.1016/S0140-6736(13)62292-8. Epub 2013 Dec 12. Erratum in: Lancet. 2014 Mar 22;383(9922):1040. Erratum in: Lancet. 2017 Mar 11;389(10073):1010.

11.

The requirements of a specialist Breast Centre.

Wilson AR, Marotti L, Bianchi S, Biganzoli L, Claassen S, Decker T, Frigerio A, Goldhirsch A, Gustafsson EG, Mansel RE, Orecchia R, Ponti A, Poortmans P, Regitnig P, Rosselli Del Turco M, Rutgers EJ, van Asperen C, Wells CA, Wengström Y, Cataliotti L; EUSOMA (European Society of Breast Cancer Specialists).

Eur J Cancer. 2013 Nov;49(17):3579-87. doi: 10.1016/j.ejca.2013.07.017. Epub 2013 Aug 19.

PMID:
23968730
12.

Doppler ultrasound flowmetry predicts 15 year outcome in patients with skin melanoma.

Srivastava A, Woodcock JP, Mansel RE, Webster DJ, Laidler P, Hughes LE, Dwivedi A.

Indian J Surg. 2012 Aug;74(4):278-83. doi: 10.1007/s12262-011-0398-z. Epub 2012 Jan 21.

13.

Comparison of the sentinel node procedure between patients with multifocal and unifocal breast cancer in the EORTC 10981-22023 AMAROS Trial: identification rate and nodal outcome.

Donker M, Straver ME, van Tienhoven G, van de Velde CJ, Mansel RE, Litière S, Werutsky G, Duez NJ, Orzalesi L, Bouma WH, van der Mijle H, Nieuwenhuijzen GA, Veltkamp SC, Helen Westenberg A, Rutgers EJ.

Eur J Cancer. 2013 Jun;49(9):2093-100. doi: 10.1016/j.ejca.2013.02.017. Epub 2013 Mar 19.

PMID:
23522754
14.

Expression of death receptor-3 in human breast cancer and its functional effects on breast cancer cells in vitro.

Ge Z, Sanders AJ, Ye L, Mansel RE, Jiang WG.

Oncol Rep. 2013 Apr;29(4):1356-64. doi: 10.3892/or.2013.2259. Epub 2013 Jan 30.

PMID:
23443464
15.

Results of a national training programme in sentinel lymph node biopsy for breast cancer.

Mansel RE, MacNeill F, Horgan K, Goyal A, Britten A, Townson J, Clarke D, Newcombe RG, Keshtgar M; Guildford Breast Surgeons; New Start Training Group, Kissin M, Layer G, Hilson A, Ell P, Wishart G, Brown D, West N.

Br J Surg. 2013 Apr;100(5):654-61. doi: 10.1002/bjs.9058. Epub 2013 Feb 6.

PMID:
23389843
16.

Epidermis instructs skin homing receptor expression in human T cells.

McCully ML, Ladell K, Hakobyan S, Mansel RE, Price DA, Moser B.

Blood. 2012 Nov 29;120(23):4591-8. doi: 10.1182/blood-2012-05-433037. Epub 2012 Oct 4.

17.

International expert consensus on primary systemic therapy in the management of early breast cancer: highlights of the Fourth Symposium on Primary Systemic Therapy in the Management of Operable Breast Cancer, Cremona, Italy (2010).

Berruti A, Generali D, Kaufmann M, Puztai L, Curigliano G, Aglietta M, Gianni L, Miller WR, Untch M, Sotiriou C, Daidone M, Conte P, Kennedy D, Damia G, Petronini P, Di Cosimo S, Bruzzi P, Dowsett M, Desmedt C, Mansel RE, Olivetti L, Tondini C, Sapino A, Fenaroli P, Tortora G, Thorne H, Bertolini F, Ferrozzi F, Danova M, Tagliabue E, de Azambuja E, Makris A, Tampellini M, Dontu G, Van't Veer L, Harris AL, Fox SB, Dogliotti L, Bottini A.

J Natl Cancer Inst Monogr. 2011;2011(43):147-51. doi: 10.1093/jncimonographs/lgr037.

PMID:
22043063
18.

Potential prognostic value of repulsive guidance molecules in breast cancer.

Li J, Ye L, Mansel RE, Jiang WG.

Anticancer Res. 2011 May;31(5):1703-11.

PMID:
21617229
19.

Clinical implications of the influence of Ehm2 on the aggressiveness of breast cancer cells through regulation of matrix metalloproteinase-9 expression.

Yu H, Ye L, Mansel RE, Zhang Y, Jiang WG.

Mol Cancer Res. 2010 Nov;8(11):1501-12. doi: 10.1158/1541-7786.MCR-10-0186. Epub 2010 Oct 5.

20.

Loss of occludin leads to the progression of human breast cancer.

Martin TA, Mansel RE, Jiang WG.

Int J Mol Med. 2010 Nov;26(5):723-34.

PMID:
20878095
21.

Bone morphogenetic protein-10 (BMP-10) inhibits aggressiveness of breast cancer cells and correlates with poor prognosis in breast cancer.

Ye L, Bokobza S, Li J, Moazzam M, Chen J, Mansel RE, Jiang WG.

Cancer Sci. 2010 Oct;101(10):2137-44. doi: 10.1111/j.1349-7006.2010.01648.x. Epub 2010 Jul 1.

22.

Investigation of anaphylactic reaction after patent blue V dye injection.

Barthelmes L, Goyal A, Sudheer P, Mansel RE.

Breast. 2010 Dec;19(6):516-20. doi: 10.1016/j.breast.2010.05.016. Epub 2010 Jun 23.

PMID:
20576435
23.

Transforming acidic coiled-coil-containing protein 2 (TACC2) in human breast cancer, expression pattern and clinical/prognostic relevance.

Cheng S, Douglas-Jones A, Yang X, Mansel RE, Jiang WG.

Cancer Genomics Proteomics. 2010 Mar-Apr;7(2):67-73.

PMID:
20335520
24.

Magnetic resonance imaging of the breast: recommendations from the EUSOMA working group.

Sardanelli F, Boetes C, Borisch B, Decker T, Federico M, Gilbert FJ, Helbich T, Heywang-Köbrunner SH, Kaiser WA, Kerin MJ, Mansel RE, Marotti L, Martincich L, Mauriac L, Meijers-Heijboer H, Orecchia R, Panizza P, Ponti A, Purushotham AD, Regitnig P, Del Turco MR, Thibault F, Wilson R.

Eur J Cancer. 2010 May;46(8):1296-316. doi: 10.1016/j.ejca.2010.02.015. Epub 2010 Mar 19.

PMID:
20304629
25.

Sentinel node identification rate and nodal involvement in the EORTC 10981-22023 AMAROS trial.

Straver ME, Meijnen P, van Tienhoven G, van de Velde CJ, Mansel RE, Bogaerts J, Duez N, Cataliotti L, Klinkenbijl JH, Westenberg HA, van der Mijle H, Snoj M, Hurkmans C, Rutgers EJ.

Ann Surg Oncol. 2010 Jul;17(7):1854-61. doi: 10.1245/s10434-010-0945-z. Epub 2010 Mar 19.

26.

Expression of MLN64 influences cellular matrix adhesion of breast cancer cells, the role for focal adhesion kinase.

Cai W, Ye L, Sun J, Mansel RE, Jiang WG.

Int J Mol Med. 2010 Apr;25(4):573-80.

PMID:
20198306
27.

Axillary node staging by ultrasonography and fine-needle aspiration cytology in patients with breast cancer.

Baruah BP, Goyal A, Young P, Douglas-Jones AG, Mansel RE.

Br J Surg. 2010 May;97(5):680-3. doi: 10.1002/bjs.6964.

PMID:
20186888
28.

Nipple-sparing skin-sparing mastectomy and vertical latissimus dorsi flap reconstruction for bilateral fibromatosis of the breast.

Al-Khyatt W, Goyal A, Mansel RE.

Clin Breast Cancer. 2010 Feb;10(1):E1-2. doi: 10.3816/CBC.2010.n.012.

PMID:
20133249
29.

PGF isoforms, PLGF-1 and PGF-2 and the PGF receptor, neuropilin, in human breast cancer: prognostic significance.

Escudero-Esparza A, Martin TA, Douglas-Jones A, Mansel RE, Jiang WG.

Oncol Rep. 2010 Feb;23(2):537-44.

PMID:
20043119
30.

Expression of the ERM family members (ezrin, radixin and moesin) in breast cancer.

Fernando H, Martin TA, Douglas-Jones A, Kynaston HG, Mansel RE, Jiang WG.

Exp Ther Med. 2010 Jan;1(1):153-160. Epub 2010 Jan 1.

31.

Role of axillary clearance after a tumor-positive sentinel node in the administration of adjuvant therapy in early breast cancer.

Straver ME, Meijnen P, van Tienhoven G, van de Velde CJ, Mansel RE, Bogaerts J, Demonty G, Duez N, Cataliotti L, Klinkenbijl J, Westenberg HA, van der Mijle H, Hurkmans C, Rutgers EJ.

J Clin Oncol. 2010 Feb 10;28(5):731-7. doi: 10.1200/JCO.2008.21.7554. Epub 2009 Dec 28.

32.

Adverse reactions to patent blue V dye - The NEW START and ALMANAC experience.

Barthelmes L, Goyal A, Newcombe RG, McNeill F, Mansel RE; NEW START and ALMANAC study groups.

Eur J Surg Oncol. 2010 Apr;36(4):399-403. doi: 10.1016/j.ejso.2009.10.007. Epub 2009 Nov 24.

PMID:
19939618
33.
34.

Reduced expression of BMPR-IB correlates with poor prognosis and increased proliferation of breast cancer cells.

Bokobza SM, Ye L, Kynaston HE, Mansel RE, Jiang WG.

Cancer Genomics Proteomics. 2009 Mar-Apr;6(2):101-8.

35.

Bone morphogenetic proteins 1 to 7 in human breast cancer, expression pattern and clinical/prognostic relevance.

Davies SR, Watkins G, Douglas-Jones A, Mansel RE, Jiang WG.

J Exp Ther Oncol. 2008;7(4):327-38.

PMID:
19227012
36.

Transcriptional and translational modulation of KAI1 expression in ductal carcinoma of the breast and the prognostic significance.

Malik FA, Sanders AJ, Jones AD, Mansel RE, Jiang WG.

Int J Mol Med. 2009 Feb;23(2):273-8.

PMID:
19148553
37.

Proceedings of the international consensus conference on breast cancer risk, genetics, & risk management, April, 2007.

Schwartz GF, Hughes KS, Lynch HT, Fabian CJ, Fentiman IS, Robson ME, Domchek SM, Hartmann LC, Holland R, Winchester DJ; Consensus Conference Committee, Anderson BO, Arun BK, Bartelink H, Bernard P, Bonanni B, Cady B, Clough KB, Feig SA, Heywang-Köbrunner SH, Howell A, Isaacs C, Kopans DB, Mansel RE, Masood S, Palazzo JP, Pressman PI, Solin LJ, Untch M.

Breast J. 2009 Jan-Feb;15(1):4-16. doi: 10.1111/j.1524-4741.2008.00665.x.

38.

The expression and prognostic value of the guanine nucleotide exchange factors (GEFs) Trio, Vav1 and TIAM-1 in human breast cancer.

Lane J, Martin TA, Mansel RE, Jiang WG.

Int Semin Surg Oncol. 2008 Oct 16;5:23. doi: 10.1186/1477-7800-5-23.

39.

Recent advances in sentinel lymph node biopsy for breast cancer.

Goyal A, Mansel RE.

Curr Opin Oncol. 2008 Nov;20(6):621-6. doi: 10.1097/CCO.0b013e328315ef1d. Review.

PMID:
18841040
40.

Eplin-alpha expression in human breast cancer, the impact on cellular migration and clinical outcome.

Jiang WG, Martin TA, Lewis-Russell JM, Douglas-Jones A, Ye L, Mansel RE.

Mol Cancer. 2008 Sep 16;7:71. doi: 10.1186/1476-4598-7-71.

41.

Detection of breast cancer metastasis in sentinel lymph nodes using intra-operative real time GeneSearch BLN Assay in the operating room: results of the Cardiff study.

Mansel RE, Goyal A, Douglas-Jones A, Woods V, Goyal S, Monypenny I, Sweetland H, Newcombe RG, Jasani B.

Breast Cancer Res Treat. 2009 Jun;115(3):595-600. doi: 10.1007/s10549-008-0155-6. Epub 2008 Aug 21.

PMID:
18716862
42.

The expression and prognostic value of ROCK I and ROCK II and their role in human breast cancer.

Lane J, Martin TA, Watkins G, Mansel RE, Jiang WG.

Int J Oncol. 2008 Sep;33(3):585-93.

PMID:
18695890
43.

Real time PCR analyses of expression of E-cadherin, alpha-, beta- and gamma-catenin in human breast cancer for predicting clinical outcome.

Goyal A, Martin TA, Mansel RE, Jiang WG.

World J Surg Oncol. 2008 Jun 11;6:56. doi: 10.1186/1477-7819-6-56.

44.

Expression of the WASP verprolin-homologues (WAVE members) in human breast cancer.

Fernando HS, Davies SR, Chhabra A, Watkins G, Douglas-Jones A, Kynaston H, Mansel RE, Jiang WG.

Oncology. 2007;73(5-6):376-83. doi: 10.1159/000136157. Epub 2008 May 29.

PMID:
18509249
45.

Lymphangiogenesis and lymph node metastasis in breast cancer.

Cunnick GH, Jiang WG, Douglas-Jones T, Watkins G, Gomez KF, Morgan MJ, Subramanian A, Mokbel K, Mansel RE.

Mol Cancer. 2008 Mar 6;7:23. doi: 10.1186/1476-4598-7-23.

46.

N-WASP is a putative tumour suppressor in breast cancer cells, in vitro and in vivo, and is associated with clinical outcome in patients with breast cancer.

Martin TA, Pereira G, Watkins G, Mansel RE, Jiang WG.

Clin Exp Metastasis. 2008;25(2):97-108. Epub 2007 Nov 6.

PMID:
17985201
47.

Morbidity in breast cancer patients with sentinel node metastases undergoing delayed axillary lymph node dissection (ALND) compared with immediate ALND.

Goyal A, Newcombe RG, Chhabra A, Mansel RE.

Ann Surg Oncol. 2008 Jan;15(1):262-7. Epub 2007 Sep 19.

PMID:
17879117
48.

Expression of transcription factor CREB1 in human breast cancer and its correlation with prognosis.

Chhabra A, Fernando H, Watkins G, Mansel RE, Jiang WG.

Oncol Rep. 2007 Oct;18(4):953-8.

PMID:
17786359
49.

The expression of the von Hippel-Lindau gene product and its impact on invasiveness of human breast cancer cells.

Zia MK, Rmali KA, Watkins G, Mansel RE, Jiang WG.

Int J Mol Med. 2007 Oct;20(4):605-11.

PMID:
17786294
50.

Matriptase-2 inhibits breast tumor growth and invasion and correlates with favorable prognosis for breast cancer patients.

Parr C, Sanders AJ, Davies G, Martin T, Lane J, Mason MD, Mansel RE, Jiang WG.

Clin Cancer Res. 2007 Jun 15;13(12):3568-76.

Supplemental Content

Loading ...
Support Center